Venkataraman Balasubramanian
Examiner (ID: 17374, Phone: (571)272-0662 , Office: P/1624 )
Most Active Art Unit | 1624 |
Art Unit(s) | 1624, 1611 |
Total Applications | 2999 |
Issued Applications | 2017 |
Pending Applications | 254 |
Abandoned Applications | 728 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5944825
[patent_doc_number] => 20110105445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'ANDROGEN RECEPTOR INACTIVATION CONTRIBUTES TO ANTITUMOR EFFICACY OF CYP17 INHIBITORS IN PROSTATE CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/921932
[patent_app_country] => US
[patent_app_date] => 2009-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10666
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20110105445.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921932
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921932 | ANDROGEN RECEPTOR INACTIVATION CONTRIBUTES TO ANTITUMOR EFFICACY OF CYP17 INHIBITORS IN PROSTATE CANCER | Mar 11, 2009 | Abandoned |
Array
(
[id] => 6178630
[patent_doc_number] => 20110178317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'MEDICINAL APPLICATIONS OF BENZOIC ACID HYDRAZONES SYNTHESIZED ON THE BASIS OF STEROIDAL TIGOGENIN'
[patent_app_type] => utility
[patent_app_number] => 12/736816
[patent_app_country] => US
[patent_app_date] => 2009-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1889
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20110178317.pdf
[firstpage_image] =>[orig_patent_app_number] => 12736816
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/736816 | Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin | Mar 2, 2009 | Issued |
Array
(
[id] => 5422976
[patent_doc_number] => 20090149431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'Eplerenone Drug Substance Having High Phase Purity'
[patent_app_type] => utility
[patent_app_number] => 12/388228
[patent_app_country] => US
[patent_app_date] => 2009-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 92
[patent_figures_cnt] => 92
[patent_no_of_words] => 25002
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20090149431.pdf
[firstpage_image] =>[orig_patent_app_number] => 12388228
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/388228 | Eplerenone Drug Substance Having High Phase Purity | Feb 17, 2009 | Abandoned |
Array
(
[id] => 8995038
[patent_doc_number] => 08518922
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-27
[patent_title] => 'Pharmaceutical solid state forms'
[patent_app_type] => utility
[patent_app_number] => 12/370510
[patent_app_country] => US
[patent_app_date] => 2009-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 29
[patent_no_of_words] => 35602
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12370510
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/370510 | Pharmaceutical solid state forms | Feb 11, 2009 | Issued |
Array
(
[id] => 5515701
[patent_doc_number] => 20090216008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'METHOD FOR THE PREPARATION OF 21-HYDROXY-6,19-OXIDOPROGESTERONE (21OH-6OP)'
[patent_app_type] => utility
[patent_app_number] => 12/367859
[patent_app_country] => US
[patent_app_date] => 2009-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5623
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20090216008.pdf
[firstpage_image] =>[orig_patent_app_number] => 12367859
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/367859 | METHOD FOR THE PREPARATION OF 21-HYDROXY-6,19-OXIDOPROGESTERONE (21OH-6OP) | Feb 8, 2009 | Abandoned |
Array
(
[id] => 5423081
[patent_doc_number] => 20090149537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'Use of Bile Acid or Bile Salt Fatty Acid Conjugates'
[patent_app_type] => utility
[patent_app_number] => 12/361291
[patent_app_country] => US
[patent_app_date] => 2009-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2707
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20090149537.pdf
[firstpage_image] =>[orig_patent_app_number] => 12361291
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/361291 | Bile acid or bile salt fatty acid conjugates | Jan 27, 2009 | Issued |
Array
(
[id] => 4634500
[patent_doc_number] => 08012951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-06
[patent_title] => '7-N-substituted phenyl tetracycline compounds'
[patent_app_type] => utility
[patent_app_number] => 12/356907
[patent_app_country] => US
[patent_app_date] => 2009-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8463
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/012/08012951.pdf
[firstpage_image] =>[orig_patent_app_number] => 12356907
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/356907 | 7-N-substituted phenyl tetracycline compounds | Jan 20, 2009 | Issued |
Array
(
[id] => 5265692
[patent_doc_number] => 20090118377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'APOGOSSYPOLONE AND THE USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/352399
[patent_app_country] => US
[patent_app_date] => 2009-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14582
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20090118377.pdf
[firstpage_image] =>[orig_patent_app_number] => 12352399
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/352399 | APOGOSSYPOLONE AND THE USES THEREOF | Jan 11, 2009 | Abandoned |
Array
(
[id] => 6149877
[patent_doc_number] => 20110021472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => '17-HYDROXY-19-NOR-21-CARBOXYLIC ACID-STEROID Y-LACTONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING THE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 12/810991
[patent_app_country] => US
[patent_app_date] => 2008-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13445
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021472.pdf
[firstpage_image] =>[orig_patent_app_number] => 12810991
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/810991 | 17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivative, use thereof, and medicament containing the derivative | Dec 22, 2008 | Issued |
Array
(
[id] => 5993509
[patent_doc_number] => 20110015162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => '15,16-Methylene-17-hydroxy-19-nor-21-carboxylic acid-steroid Y-lactone derivative, use thereof and medicinal products containing the derivative'
[patent_app_type] => utility
[patent_app_number] => 12/811002
[patent_app_country] => US
[patent_app_date] => 2008-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13937
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20110015162.pdf
[firstpage_image] =>[orig_patent_app_number] => 12811002
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/811002 | 15,16-Methylene-17-hydroxy-19-nor-21-carboxylic acid-steroid Y-lactone derivative, use thereof and medicinal products containing the derivative | Dec 22, 2008 | Abandoned |
Array
(
[id] => 6630208
[patent_doc_number] => 20100311702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => '19-NOR-STEROID DERIVATIVES WITH A 15ALPHA, 16ALPHA-METHYLENE GROUP AND A SATURATED 17, 17-SPIRO-LACTONE RING, USE THEREOF, AND MEDICAMENTS CONTAINING SAID DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/810860
[patent_app_country] => US
[patent_app_date] => 2008-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8522
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311702.pdf
[firstpage_image] =>[orig_patent_app_number] => 12810860
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/810860 | 19-NOR-STEROID DERIVATIVES WITH A 15ALPHA, 16ALPHA-METHYLENE GROUP AND A SATURATED 17, 17-SPIRO-LACTONE RING, USE THEREOF, AND MEDICAMENTS CONTAINING SAID DERIVATIVES | Dec 22, 2008 | Abandoned |
Array
(
[id] => 6388081
[patent_doc_number] => 20100317632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => '17-(1\'PROPENYL)-17-3\'-OXIDOESTRA-4-EN-3-ONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING SAID DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 12/810858
[patent_app_country] => US
[patent_app_date] => 2008-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12058
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317632.pdf
[firstpage_image] =>[orig_patent_app_number] => 12810858
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/810858 | 17-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative | Dec 22, 2008 | Issued |
Array
(
[id] => 5586003
[patent_doc_number] => 20090105205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'METHODS OF TREATING DISEASE STATES USING ANTIANGIOGENIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/341068
[patent_app_country] => US
[patent_app_date] => 2008-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15829
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20090105205.pdf
[firstpage_image] =>[orig_patent_app_number] => 12341068
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/341068 | Methods of treating disease states using antiangiogenic agents | Dec 21, 2008 | Issued |
Array
(
[id] => 5546690
[patent_doc_number] => 20090156567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'NOVEL ANTI-INFLAMMATORY ANDROSTANE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 12/339607
[patent_app_country] => US
[patent_app_date] => 2008-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17023
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20090156567.pdf
[firstpage_image] =>[orig_patent_app_number] => 12339607
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/339607 | NOVEL ANTI-INFLAMMATORY ANDROSTANE DERIVATIVE | Dec 18, 2008 | Abandoned |
Array
(
[id] => 6163069
[patent_doc_number] => 20110160167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'Steroid Derivatives Acting As Glucocorticosteroid Receptor Agonists'
[patent_app_type] => utility
[patent_app_number] => 12/809131
[patent_app_country] => US
[patent_app_date] => 2008-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18464
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160167.pdf
[firstpage_image] =>[orig_patent_app_number] => 12809131
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/809131 | Steroid Derivatives Acting As Glucocorticosteroid Receptor Agonists | Dec 17, 2008 | Abandoned |
Array
(
[id] => 6003785
[patent_doc_number] => 20110118488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'PROCESS FOR OBTAINING 6-ALKYLIDENANDROST-1, 4-DIENE-3-ONE'
[patent_app_type] => utility
[patent_app_number] => 12/747677
[patent_app_country] => US
[patent_app_date] => 2008-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8699
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20110118488.pdf
[firstpage_image] =>[orig_patent_app_number] => 12747677
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/747677 | PROCESS FOR OBTAINING 6-ALKYLIDENANDROST-1, 4-DIENE-3-ONE | Dec 11, 2008 | Abandoned |
Array
(
[id] => 5546966
[patent_doc_number] => 20090156843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'PROCESS FOR AROMATIZING 19-NORANDROST-4-EN-3-ONES TO ESTRA-1,3,5(10)-TRIENES'
[patent_app_type] => utility
[patent_app_number] => 12/334048
[patent_app_country] => US
[patent_app_date] => 2008-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5169
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20090156843.pdf
[firstpage_image] =>[orig_patent_app_number] => 12334048
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/334048 | PROCESS FOR AROMATIZING 19-NORANDROST-4-EN-3-ONES TO ESTRA-1,3,5(10)-TRIENES | Dec 11, 2008 | Abandoned |
Array
(
[id] => 8577959
[patent_doc_number] => 08344168
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-01
[patent_title] => 'Process for the preparation of fluticasone propionate'
[patent_app_type] => utility
[patent_app_number] => 12/329790
[patent_app_country] => US
[patent_app_date] => 2008-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7878
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12329790
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/329790 | Process for the preparation of fluticasone propionate | Dec 7, 2008 | Issued |
Array
(
[id] => 74332
[patent_doc_number] => 07749989
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-06
[patent_title] => 'Estrogenic compounds, methods of using and methods of administering the same'
[patent_app_type] => utility
[patent_app_number] => 12/276511
[patent_app_country] => US
[patent_app_date] => 2008-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 13314
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/749/07749989.pdf
[firstpage_image] =>[orig_patent_app_number] => 12276511
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/276511 | Estrogenic compounds, methods of using and methods of administering the same | Nov 23, 2008 | Issued |
Array
(
[id] => 5502768
[patent_doc_number] => 20090163456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'CARBONATE AND CARBAMATE MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH B2 ADRENERGIC AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/277004
[patent_app_country] => US
[patent_app_date] => 2008-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5744
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20090163456.pdf
[firstpage_image] =>[orig_patent_app_number] => 12277004
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/277004 | Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists | Nov 23, 2008 | Issued |